Total Payments
$11,035
2024 Payments
$1,634
Companies
56
Transactions
708
Medicare Patients
12,240
Medicare Billing
$772,457
Payment Breakdown by Category
Food & Beverage$10,904 (98.8%)
Education$130.67 (1.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,904 | 703 | 98.8% |
| Education | $130.67 | 5 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,986 | 162 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,336 | 80 | $0 (2024) |
| ABBVIE INC. | $917.72 | 56 | $0 (2024) |
| Lilly USA, LLC | $664.00 | 39 | $0 (2024) |
| PFIZER INC. | $638.93 | 47 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $625.02 | 35 | $0 (2024) |
| GlaxoSmithKline, LLC. | $576.47 | 35 | $0 (2024) |
| Amgen Inc. | $490.32 | 30 | $0 (2024) |
| Astellas Pharma US Inc | $447.53 | 21 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $372.79 | 25 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,634 | 87 | Novo Nordisk Inc ($313.26) |
| 2023 | $1,679 | 86 | ABBVIE INC. ($285.64) |
| 2022 | $1,706 | 94 | Novo Nordisk Inc ($236.81) |
| 2021 | $1,464 | 98 | Novo Nordisk Inc ($220.53) |
| 2020 | $576.87 | 42 | Novo Nordisk Inc ($113.98) |
| 2019 | $1,216 | 90 | Novo Nordisk Inc ($328.50) |
| 2018 | $1,343 | 102 | Novo Nordisk Inc ($218.95) |
| 2017 | $1,416 | 109 | Novo Nordisk Inc ($316.76) |
All Payment Transactions
708 individual payment records from CMS Open Payments — Page 1 of 29
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Bausch Health US, LLC | WELLBUTRIN (Drug), APLENZIN | Food and Beverage | In-kind items and services | $28.58 | General |
| Category: Neurology | ||||||
| 12/17/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.87 | General |
| Category: Diabetes | ||||||
| 12/03/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $20.92 | General |
| Category: Obesity | ||||||
| 12/02/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: Respiratory | ||||||
| 11/25/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $7.26 | General |
| Category: NEUROSCIENCE | ||||||
| 11/22/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: Inflammation | ||||||
| 11/19/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.53 | General |
| Category: Oncology | ||||||
| 11/18/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: Diabetes | ||||||
| 11/18/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: Respiratory | ||||||
| 11/15/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: PAIN | ||||||
| 11/11/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: Diabetes | ||||||
| 11/07/2024 | VIVUS LLC | QSYMIA (Drug) | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: Diabetes | ||||||
| 10/31/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.56 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.51 | General |
| Category: PAIN | ||||||
| 10/21/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: NEUROSCIENCE | ||||||
| 10/18/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.78 | General |
| Category: Respiratory | ||||||
| 10/15/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $22.53 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 10/14/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $9.11 | General |
| Category: NEUROSCIENCE | ||||||
| 10/08/2024 | Bausch Health US, LLC | WELLBUTRIN (Drug), APLENZIN | Food and Beverage | In-kind items and services | $23.82 | General |
| Category: Neurology | ||||||
| 09/30/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: Diabetes | ||||||
| 09/17/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $27.99 | General |
| Category: NEUROSCIENCE | ||||||
| 09/16/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: Obesity | ||||||
| 09/09/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $23.76 | General |
| Category: Diabetes | ||||||
| 09/03/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $20.35 | General |
| Category: UROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 27 | 3,030 | 4,097 | $545,166 | $193,391 |
| 2022 | 27 | 3,088 | 3,990 | $519,276 | $199,544 |
| 2021 | 25 | 3,039 | 3,884 | $494,857 | $205,141 |
| 2020 | 30 | 3,083 | 3,911 | $488,310 | $174,381 |
Total Patients
12,240
Total Services
15,882
Medicare Billing
$772,457
Procedure Codes
109
All Medicare Procedures & Services
109 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 306 | 550 | $126,265 | $40,133 | 31.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 311 | 311 | $47,484 | $36,766 | 77.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 290 | 373 | $117,598 | $36,227 | 30.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 213 | 384 | $68,250 | $20,581 | 30.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 189 | 190 | $19,748 | $12,760 | 64.6% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 29 | 29 | $9,158 | $7,887 | 86.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 191 | 192 | $9,398 | $5,513 | 58.7% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 316 | 316 | $11,343 | $5,263 | 46.4% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 24 | 24 | $7,320 | $3,640 | 49.7% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 66 | 85 | $10,354 | $3,325 | 32.1% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 21 | 21 | $4,820 | $3,178 | 65.9% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 68 | 174 | $14,734 | $2,757 | 18.7% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 15 | 16 | $4,075 | $2,260 | 55.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 217 | 230 | $26,176 | $2,039 | 7.8% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 35 | 40 | $3,462 | $1,885 | 54.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 36 | 209 | $12,937 | $1,797 | 13.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 46 | 54 | $6,038 | $1,752 | 29.0% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 36 | 50 | $5,544 | $1,076 | 19.4% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 157 | 159 | $12,378 | $966.09 | 7.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 31 | 31 | $1,514 | $875.10 | 57.8% |
| 81003 | Automated urinalysis test | Office | 2023 | 264 | 308 | $9,515 | $681.06 | 7.2% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 22 | 22 | $3,847 | $634.42 | 16.5% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 13 | 15 | $1,800 | $532.28 | 29.6% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 23 | 24 | $1,726 | $372.60 | 21.6% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 58 | 64 | $3,003 | $199.04 | 6.6% |
About Dr. Joan Meehan, DO
Dr. Joan Meehan, DO is a Family Medicine healthcare provider based in Clayton, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1437111341.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joan Meehan, DO has received a total of $11,035 in payments from pharmaceutical and medical device companies, with $1,634 received in 2024. These payments were reported across 708 transactions from 56 companies. The most common payment nature is "Food and Beverage" ($10,904).
As a Medicare-enrolled provider, Meehan has provided services to 12,240 Medicare beneficiaries, totaling 15,882 services with total Medicare billing of $772,457. Data is available for 4 years (2020–2023), covering 109 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Clayton, NC
- Active Since 04/05/2006
- Last Updated 03/25/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1437111341
Products in Payments
- FARXIGA (Drug) $779.35
- Saxenda (Drug) $706.78
- Ozempic (Drug) $505.30
- UBRELVY (Drug) $463.09
- JARDIANCE (Drug) $442.84
- Wegovy (Drug) $310.86
- MOUNJARO (Drug) $307.71
- Aimovig (Biological) $291.84
- QULIPTA (Drug) $273.71
- APLENZIN (Drug) $223.46
- NURTEC ODT (Drug) $210.20
- TOUJEO (Drug) $207.61
- TRELEGY ELLIPTA (Drug) $198.99
- Rybelsus (Drug) $198.16
- Kerendia (Drug) $184.18
- Myrbetriq (Drug) $169.05
- AIRSUPRA (Drug) $164.64
- VRAYLAR (Drug) $137.65
- Vascepa (Drug) $132.80
- WELLBUTRIN (Drug) $132.51
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Clayton
Bhavna Vaidya-Tank, Md, MD
Family Medicine — Payments: $11,671
Family Medicine $11,671
Brian Pratt, Md, MD
Family Medicine — Payments: $9,650
Family Medicine $9,650
Dr. Steven Kaplan, M.d, M.D
Family Medicine — Payments: $8,325
Family Medicine $8,325
Dr. William Hebda, M.d, M.D
Family Medicine — Payments: $4,334
Family Medicine $4,334
Dr. Aaron Huizenga, D.o, D.O
Family Medicine — Payments: $4,229
Family Medicine $4,229
Dr. Jana Tomsky, M.d, M.D
Family Medicine — Payments: $4,224
Family Medicine $4,224